Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.8 USD | -4.89% | -9.15% | -29.93% |
May. 14 | Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down | MT |
Financials (USD)
Sales 2024 * | 78M | Sales 2025 * | - | Capitalization | 261M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 4M | EV / Sales 2024 * | 3.35 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-138
x | P/E ratio 2025 * |
54.1
x | Employees | 108 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.95% |
Latest transcript on Sanara MedTech Inc.
1 day | +0.53% | ||
1 week | -2.96% | ||
Current month | -3.38% | ||
1 month | -5.64% | ||
3 months | -18.98% | ||
6 months | -6.24% | ||
Current year | -25.15% |
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 18-04-10 |
Chief Tech/Sci/R&D Officer | - | 22-12-31 | |
Chief Tech/Sci/R&D Officer | 39 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 21-12-31 |
Roszell Mack
BRD | Director/Board Member | 57 | 21-12-31 |
Eric Major
BRD | Director/Board Member | 55 | 23-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.06% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 28.8 | -4.89% | 36 223 |
24-05-22 | 30.28 | -3.90% | 15,276 |
24-05-21 | 31.51 | -3.14% | 6,321 |
24-05-20 | 32.53 | +6.62% | 12,948 |
24-05-17 | 30.51 | -3.75% | 17,482 |
Delayed Quote Nasdaq, May 23, 2024 at 10:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.15% | 261M | |
+38.61% | 723B | |
+34.09% | 595B | |
-3.00% | 369B | |
+20.68% | 332B | |
+2.65% | 282B | |
+17.42% | 244B | |
+9.59% | 208B | |
-4.58% | 205B | |
+0.45% | 168B |
- Stock Market
- Equities
- SMTI Stock